News | Cath Lab | May 24, 2016

SCAI 2016 Late-breaking Trial Presesentations

The latest interventional cardiology trial data presented at the Society for Cardiovascular Angiography and Interventions 2016 Scientific Sessions


The Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Scientific Sessions took place May 4-7, 2016 in Orlando, Fla. The event included data from clinical trials on some of the latest advances in interventional cardiology. The late-breaking clinical trials presentations include the following, including links to related stories on these trials:

Wednesday, May 4, 1:15 - 2:15 p.m. Eastern Time

• Effect of the AVERT Contrast Modulation System on Contrast Dose Reduction and Acute Kidney Injury After Coronary Angiography and PCI, presented by Roxana Mehran, M.D., FSCAI.

• Clinical Evaluation of the Cadence Device in the Acoustic Detection of Coronary Artery Disease: The TURBULENCE Study, presented by Joseph Thomas, M.D., FSCAI.

• Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the Complex Robotically Assisted Percutaneous Coronary Intervention (CORA-PCI) Trial, presented by Ehtisham Mahmud, M.D., FSCAI.

• Risk Directed Interventions in Percutaneous Coronary Intervention (PCI):  An Enterprise Approach for Reducing Bleeding Events, presented by Jerome E. Granato, M.D.


Thursday, May 5, 10:30 - 11:30 a.m. Eastern Time
 Plaque Morphology Predictors of Side Branch Occlusion after Provisional Stenting in Coronary Bifurcation Lesion: Results of Optical Coherence Tomography Bifurcation Study (ORBID), presented by Annapoorna Kini, M.D.

• Final Results for THE ATHENA TRIALS: Autologous Adipose Derived Regenerative Cells (ADRCs) for Refractory Chronic Myocardial Ischemia with Left Ventricular (LV) Dysfunction, presented by Timothy D. Henry, M.D., MSCAI.

• Efficacy of STENTYS Self-Apposing Bare Metal Nitinol Stents in Patients Undergoing Primary PCI: Results from the APPOSITION V Trial, presented by Roxana Mehran, M.D., FSCAI.

• Final Results for the Renew Trial: A Phase 3, Randomized, Double Blinded, Active-Controlled, Unblinded Standard of Care Study Assessing the Efficacy and Safety of Intramyocardial Autologous CD34+ Cell Administration in Patients with Refractory Angina, presented by Timothy D. Henry, M.D., MSCAI.


Friday, May 6 | 9:00 a.m. to 10:00 a.m. Eastern Time
• Sex Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: From the STS/ACC TVT Registry, presented by Roxana Mehran, M.D., FSCAI.

• Sex-Based Differences in Patients Less than 50 Years of Age Undergoing PCI for Acute Coronary Syndromes, presented by Jaya Chandrasekhar, MBBS.

• Moderate vs. General Anesthesia for Transcatheter Aortic Valve Replacement: An STS/ACC Transcatheter Valve Therapy Registry Analysis, presented by Jay Giri, M.D., MPH.

• Sex Based Differences in Outcomes with Bivalirudin or Unfractionated Heparin for Transcatheter Aortic Valve Replacement: Results from the BRAVO 3 Randomized Trial, presented by Anita W. Asgar, M.D.

For more information on the late-breaking trials and featured clinical research being presented at the meeting, visit:  

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott While Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init